Stock ERAS ERASCA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Erasca, Inc.

Equities

ERAS

US29479A1088

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
2.11 USD +3.94% Intraday chart for Erasca, Inc. -2.76% -0.94%
06-18 Erasca, Inc. Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma CI
05-21 Erasca Closes Oversubscribed Share Offering to Raise $184 Million MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma
AQ
Erasca, Inc. Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma
CI
Erasca to Present at Upcoming Investor Conferences in June
AQ
Erasca : Investor Update May 2024
PU
Erasca Closes Oversubscribed Share Offering to Raise $184 Million
MT
Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
AQ
Erasca : Corporate Presentation May 2024
PU
Erasca Acquires 2 Exclusive Worldwide Licenses for Preclinical RAS Programs
MT
Erasca Prices $160 Million Common Stock Offering
MT
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
AQ
Erasca Announces Pricing of Underwritten Offering of Common Stock
AQ
Erasca Reports First Quarter 2024 Business Updates and Financial Results
GL
Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Erasca to Present at the Bank of America Health Care Conference
AQ
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
AQ
North American Morning Briefing : Powell Awaited -2-
DJ
Goldman Sachs Adjusts Erasca's Price Target to $7 From $6, Maintains Buy Rating
MT
Erasca, Inc. announced that it has received $45 million in funding
CI
Erasca Announces $45 Million Oversubscribed Private Placement Financing
GL
Erasca, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ERAS Stock
  4. News Erasca, Inc.